sulfadoxine/pyrimethamine

DRUG5 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Centers for Disease Control and Prevention, London School of Hygiene and Tropical Medicine

Conditions

HIV InfectionsMalariaPlasmodium Falciparum MalariaPneumonia, Pneumocystis Carinii

Phase 3

A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)

CompletedNCT00000727

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Pneumonia, Pneumocystis Carinii

End: 1991-08-31Target: 322Updated: 2021-11-03

SP Resistance and Falciparum Malaria Transmission

WithdrawnNCT00299247

National Institute of Allergy and Infectious Diseases (NIAID)Plasmodium Falciparum Malaria

End: 2006-12-31Updated: 2019-01-30

IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.

TerminatedNCT00361114

London School of Hygiene and Tropical MedicineMalaria

Start: 2006-07-31End: 2007-10-31Updated: 2017-01-26

Phase 4

CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in Malawi

CompletedNCT00125489

National Institute of Allergy and Infectious Diseases (NIAID)Malaria, Plasmodium Falciparum Malaria

Start: 2005-05-31End: 2005-12-31Target: 210Updated: 2010-08-27

Efficacy of Combination Therapy for Prevention of Effects of Malaria During Pregnancy

CompletedNCT00164255

Centers for Disease Control and PreventionMalaria

Start: 2003-01-31End: 2009-06-30Updated: 2012-09-11

Related Papers

High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581.

2009-02-24132 citations